Skip to main content
Clinical Trials/ISRCTN10285713
ISRCTN10285713
Active, not recruiting
未知

europsychological Evaluation and Rehabilitation in Multiple Sclerosis (NEuRoMS): A mixed methods pragmatic multicentre Randomised Controlled Trial (RCT) with nested health economic and process evaluations and an implementation study (Phase 3: Work Packages 4 and 5)

ottinghamshire Healthcare NHS Foundation Trust0 sites4,776 target enrollmentMarch 11, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
ottinghamshire Healthcare NHS Foundation Trust
Enrollment
4776
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 11, 2024
End Date
July 31, 2027
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
ottinghamshire Healthcare NHS Foundation Trust

Eligibility Criteria

Inclusion Criteria

  • Current participant inclusion criteria as of 17/05/2024:
  • All individuals: Able and willing to give consent and able to communicate in English. Participant information sheets can be provided in Welsh upon request but the standardised materials and tests to be used require communication in English since these have not yet been developed for other languages.
  • Part 1: People with MS:
  • 1\.1\. Diagnosis of MS
  • 1\.2\. Aged 18 years or above
  • Part 2: People with MS:
  • 2\.1\. Aged 18 years or above
  • 2\.2\. Diagnosis of MS
  • 2\.3\. Received cognitive screening, and mild or moderate cognitive problems identified (Part 1\):
  • Mild or moderate problems will be identified by the clinical team based on the screening scores, the clinical and contextual information collected as part of the cognitive screening, and the patient\-clinician conversations on cognitive problems experienced.

Exclusion Criteria

  • 1\. All participants: Do not have mental capacity to consent to participate in the study.
  • Part 2 participants only:
  • 2\.1\. Currently receiving neuropsychological intervention for cognitive problems
  • 2\.2\. Received NEuRoMS intervention during WP2ii or WP3\.
  • Part 3 patient participants only:
  • 3\.1\. Participated in Part 4 interviews.
  • Part 4 patient participants only:
  • 4\.1\. Participated in Part 3 interviews.

Outcomes

Primary Outcomes

Not specified

Similar Trials